A population-based study evaluating the safety after vaccination with BNT162b2 and CoronaVac showed an increased risk of haemorrhagic stroke after both first and second doses of BNT162b2 but not after CoronaVac. However, no increased risk of thromboembolic events was observed with either vaccine. Still, the incidence of both outcomes was...
Thromboembolic events and haemorrhagic stroke after COVID-19 vaccination
Heather Mason
|
Medical News
|
01 July 2022
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.
Create a Free Account I have an account